Study of 55 countries shows wide variation in self-reported screening prevalence.
The combination had manageable toxicity in phase 2 CLAP study.
Adding bevacizumab does not have any additional benefit.
Pre- and postdiagnosis activity improves survival.
Dostarlimab has acceptable safety profile.
Dr Sanchez Conde discussed current data regarding HIV in older women, highlighting an increased risk of early menopause and cancer in women with HIV.
The reduction was even greater in women vaccinated before the age of 17 years.
A PREMM5 score at or above 2.5% warrants consideration of multigene panel testing.
Overall survival was similar in women treated with fertility-sparing surgery and radical surgery.
The proportion of endometrial tumours associated with Lynch syndrome: A prospective cross-sectional study.
Prolonging the platinum-free interval using trabectedin after recurrence failed to improve overall survival compared to carboplatin.
An analysis of data from high-risk women referred to the Manchester Centre for Genomic Medicine with ovarian cancer.
Preliminary safety data from phase 2 study.
A 101-gene expression signature called OTTA-SPOT.
Annual report from Public Health Scotland.
High infiltration is associated with improved survival after chemoradiation.
KRAS mutation is associated with significant PFS improvement with binimetinib.
